Use of beta-human chorionic gonadotropin in gestational aging

Area of Science:

• Reproductive Endocrinology
• Clinical Chemistry
• Immunoassay Development

Background:

• Early pregnancy assessment is crucial for maternal and fetal health.
• Human chorionic gonadotropin (hCG) is a key biomarker for pregnancy.
• Radioimmunoassay (RIA) is a sensitive method for quantifying hormones.

Purpose of the Study:

• To evaluate the utility of quantitative serum beta-hCG RIA for assessing early pregnancy status.
• To compare the accuracy of serum and urinary hCG RIA for gestational dating.
• To identify characteristics of reliable hCG RIA assays for clinical application.

Main Methods:

• Quantitative serum and urinary hCG RIA were performed on samples from normal and complicated pregnancies.
• Assays were standardized against the second international standard (2dIS).
• Assay performance characteristics including linearity, parallelism, cross-reactivity, and nonspecific binding were evaluated.

Main Results:

• Serum B-hCG RIA accurately determined gestational age in normal pregnancies up to three weeks postconception and within ±4 days between weeks 3-8.
• Quantitative urinary hCG RIA was not useful for gestational aging.
• Specific assay characteristics (linearity, parallelism, low cross-reactivity/binding) were essential for detecting ectopic and threatened pregnancies with up to 90% accuracy.
• Non-standardized assays showed significant errors (>200%) in serum hCG values.

Conclusions:

• Quantitative serum beta-hCG RIA, when properly standardized, is a valuable tool for early pregnancy assessment and diagnosis of complications.
• The choice of standardized reagents is critical for reliable clinical results.
• Urinary hCG RIA is not recommended for gestational dating.